| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.22 | 0.09 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.29 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |